Investigational Site Number 032002

San Miguel de Tucumán T4000ICL

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Idiopathic Pulmonary Fibrosis

Studies at this site

• Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis — Completed
• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed